This protocol is judged by an institutional review board, an unbiased team that reviews any scientific trials involving humans. If a review requires a Agenda I drug, after the board approves the protocol as moral, the scientists really have to make an application for an investigational new drug (IND) amount in the FDA. “Now we have to possess